← All stocks

Schrodinger, Inc.

SDGR Net selling
CIK 0001490978 #2259 in the set updated 22 Sep 2026
Bought (120 mo)
$14.36M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$1.05B
$988.42K on a plan · $191.09M straight out of an exercise
Sold at will
$862.72M
508 of 712 sales
Net
−$1.04B
−$848.36M against sales at will

By person

28 insiders · 728 transactions
16.6×

Ramy Farid holds 16.6 times base salary in stock. $12.16M of shares against $730.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Ramy Farid last reported holding, valued at $30.00, the price Common Stock was last bought or sold at on the open market here, on 17 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
SHAW DAVID E
10% owner
$677.54M (444)
−$677.54M
6,196,609
8.3%
$185.90M
+6,839%
BILL & MELINDA GATES FOUNDATION TRUST entity
10% owner
$10.00M (1)
$256.49M (6)
−$246.49M
6,981,664
9.3%
$209.45M
Friesner Richard
Director
$37.96M (18)
−$37.96M
2,092,991
2.8%
$62.79M
−16.4%
Lebowitz Joel
EVP & CFO
$111.39K (1)
$14.09M (38) scheduled
−$13.98M
0
0.000%
$0.00
Farid Ramy
President & CEO
$12.37M (15)
−$12.37M
405,351
0.543%
$12.16M
+21.2%
Abel Robert Lorne
See Remarks
$10.67M (24) scheduled
−$10.67M
55,897
0.075%
$1.68M
+4.5%
Akinsanya Karen
See Remarks
$7.64M (29) scheduled
−$7.64M
69,956
0.094%
$2.10M
Weiser Jorg
EVP & Managing Director
$7.17M (11) scheduled
−$7.17M
134,442
0.180%
$4.03M
−27.2%
Daniel Jennifer
EVP & Chief HR Officer
$7.06M (31) scheduled
−$7.06M
6,688
0.009%
$200.64K
−78.1%
Tran Yvonne
EVP, CLO & CPO
$6.88M (25) scheduled
−$6.88M
52,683
0.071%
$1.58M
+31.3%
D'Cruz Cony
EVP & Chief Business Officer
$5.80M (26) scheduled
−$5.80M
147,082
0.197%
$4.41M
−15.0%
Flynn James E
10% owner
$4.25M (1)
+$4.25M
1,596,167
2.1%
$47.89M
Lorton Kenneth Patrick
EVP, CTO & COO, Software
$3.49M (10)
−$3.49M
89,241
0.119%
$2.68M
+25.9%
Lynton Michael
Director
$2.00M (3) scheduled
−$2.00M
25,388
0.034%
$761.64K
Sender Gary
Director
$1.91M (1) scheduled
−$1.91M
25,388
0.034%
$761.64K
Brauner Shane
EVP & CIO
$1.32M (8) scheduled
−$1.32M
24,867
0.033%
$746.01K
+6.2%
Ardai Charles
10% owner
$866.00K (2)
−$866.00K
0
0.000%
$0.00
−100.0%
Thornberry Nancy
Director
$693.00K (2) scheduled
−$693.00K
25,388
0.034%
$761.64K
Herman Jenny
CAO
$463.33K (11)
−$463.33K
34,804
0.047%
$1.04M
+567.1%
Porges Geoffrey Craig
EVP & CFO
$206.84K (2)
−$206.84K
27,544
0.037%
$826.32K
Kapeller-Libermann Rosana
Director
$75.00K (1) scheduled
−$75.00K
25,388
0.034%
$761.64K
Dugan Margaret
Chief Medical Officer
$56.61K (2) scheduled
−$56.61K
24,574
0.033%
$737.22K
Jain Rachit
EVP & CFO
$45.44K (3) scheduled
−$45.44K
50,877
0.068%
$1.53M
+83.5%
Aklian Mannix Vartan
See Remarks
31,193
0.042%
$935.79K
Chodakewitz Jeffrey
Director
25,388
0.034%
$761.64K
OBEROI ARUN
Director
25,388
0.034%
$761.64K
GINSBERG GARY L
Director
25,388
0.034%
$761.64K
van Kralingen Bridget A
Director
19,640
0.026%
$589.20K
Insider
Date
Role
Action
Shares
Price
Amount
Akinsanya Karen
17 Sep 2026
See Remarks
Sold after exercise
21,599
$30.00
$647.97K
Akinsanya Karen
17 Sep 2026
See Remarks
Sold after exercise
10,000
$28.00
$280.00K
Farid Ramy
17 Apr 2026
President & CEO
Sold after exercise
43,000
$12.21
$524.94K
Farid Ramy
16 Apr 2026
President & CEO
Sold after exercise
43,000
$12.33
$530.23K
Akinsanya Karen
14 Apr 2025
President of R&D, Therapeutics
Sold after exercise
3,345
$25.00
$83.63K
Akinsanya Karen
14 Apr 2025
President of R&D, Therapeutics
Sold after exercise
5,000
$25.11
$125.55K
Akinsanya Karen
14 Apr 2025
President of R&D, Therapeutics
Sold after exercise
8,378
$25.11
$210.39K
Tran Yvonne
18 Feb 2025
EVP, CLO & CPO
Sold after exercise
3,902
$28.00
$109.26K
Tran Yvonne
30 Jun 2023
EVP, CLO & CPO
Sold after exercise
12,040
$50.00
$602.00K
Tran Yvonne
23 May 2023
EVP, CLO & CPO
Sold after exercise
7,960
$40.01
$318.46K
Thornberry Nancy
22 May 2023
Director
Sold after exercise
14,850
$35.00
$519.75K
Tran Yvonne
22 May 2023
EVP, CLO & CPO
Sold after exercise
15,000
$35.04
$525.63K
Tran Yvonne
2 Feb 2023
EVP & Chief Legal Officer
Sold after exercise
25,000
$27.26
$681.38K
Farid Ramy
4 Jan 2023
President & CEO
Sold after exercise
66,886
$18.28
$1.22M
Thornberry Nancy
11 Aug 2022
Director
Sold after exercise
4,950
$35.00
$173.25K
Abel Robert Lorne
13 Dec 2021
See Remarks
Sold after exercise
1,900
$36.88
$70.08K
Abel Robert Lorne
13 Dec 2021
See Remarks
Sold after exercise
13,701
$36.20
$495.91K
Akinsanya Karen
15 Oct 2021
See Remarks
Sold after exercise
1,393
$55.75
$77.66K
Akinsanya Karen
15 Sep 2021
See Remarks
Sold after exercise
1,394
$61.13
$85.22K
Abel Robert Lorne
13 Sep 2021
See Remarks
Sold after exercise
9,782
$62.14
$607.90K
Abel Robert Lorne
13 Sep 2021
See Remarks
Sold after exercise
5,820
$61.09
$355.54K
Lebowitz Joel
2 Sep 2021
EVP & CFO
Sold after exercise
3,874
$64.62
$250.35K
Lebowitz Joel
1 Sep 2021
EVP & CFO
Sold after exercise
1,700
$64.53
$109.70K
Akinsanya Karen
16 Aug 2021
See Remarks
Sold after exercise
16,047
$58.17
$933.53K
Akinsanya Karen
16 Aug 2021
See Remarks
Sold after exercise
21,691
$57.43
$1.25M
Lebowitz Joel
14 Jul 2021
EVP & CFO
Sold after exercise
305
$69.45
$21.18K
Lebowitz Joel
14 Jul 2021
EVP & CFO
Sold after exercise
2,762
$68.35
$188.79K
Lebowitz Joel
14 Jul 2021
EVP & CFO
Sold after exercise
2,507
$67.53
$169.30K
Abel Robert Lorne
21 Jun 2021
See Remarks
Sold after exercise
15,602
$74.16
$1.16M
Lebowitz Joel
14 Jun 2021
EVP & CFO
Sold after exercise
200
$78.60
$15.72K
Lebowitz Joel
14 Jun 2021
EVP & CFO
Sold after exercise
3,281
$77.82
$255.32K
Lebowitz Joel
14 Jun 2021
EVP & CFO
Sold after exercise
2,093
$76.53
$160.18K
Akinsanya Karen
8 Jun 2021
See Remarks
Sold after exercise
800
$76.08
$60.86K
Akinsanya Karen
8 Jun 2021
See Remarks
Sold after exercise
9,442
$75.49
$712.78K
Akinsanya Karen
7 Jun 2021
See Remarks
Sold after exercise
6,479
$75.10
$486.57K
Kapeller-Libermann Rosana
7 Jun 2021
Director
Sold after exercise
1,000
$75.00
$75.00K
Lebowitz Joel
18 May 2021
EVP & CFO
Sold after exercise
5,574
$64.45
$359.24K
Abel Robert Lorne
5 May 2021
See Remarks
Sold after exercise
954
$71.02
$67.75K
Abel Robert Lorne
5 May 2021
See Remarks
Sold after exercise
8,490
$69.97
$594.07K
Abel Robert Lorne
5 May 2021
See Remarks
Sold after exercise
6,429
$68.97
$443.42K
Lebowitz Joel
14 Apr 2021
EVP & CFO
Sold after exercise
16
$79.73
$1.28K
Lebowitz Joel
14 Apr 2021
EVP & CFO
Sold after exercise
1,498
$79.08
$118.47K
Lebowitz Joel
14 Apr 2021
EVP & CFO
Sold after exercise
3,860
$78.26
$302.07K
Lebowitz Joel
14 Apr 2021
EVP & CFO
Sold after exercise
200
$76.91
$15.38K
Showing 250 of 728 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 289
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 38
Sales on a Rule 10b5-1 plan 28
Sales straight out of an exercise 176
Sales at will 508
Transactions with no price 0
Shares from compensation/vesting 31,609,483
Sales filed before the plan box existed 505
History held since 10 Feb 2020